Angle (AGL)

 

Latest News

ISSUE OF SHARE OPTIONS

RNS Number: 2366Q Angle PLC 28 November 2016 For immediate release 28 November 2016 ANGLE plc ("ANGLE" or the "Company") ISSUE OF SHARE OPTIONS ANGLE plc (AIM: AGL; OTCQX: ANPCY), the specialist medtech company, announces that under the shareholder approved Remuneration Policy the Remuneration Committee has approved the issu...

Result of GM

RNS Number: 1072Q Angle PLC 24 November 2016 For Immediate Release 24 November 2016 ANGLE plc ("ANGLE" or "the Company") Result of 24 November 2016 General Meeting ANGLE plc (AIM: AGL OTCQX: ANPCY), the specialist medtech company, announces that the Resolution put to its shareholders at today's General Meeting was duly passed. For furt...

ANGLE welcomes new research supporting Parsortix

ANGLE, the specialist medtech company, welcomes new research which supports the potential use of the company's Parso...

Barts Research Supports Potential Use of Parsortix

RNS Number: 2829O Angle PLC 04 November 2016 For immediate release 4 November 2016 ANGLE plc ("ANGLE" or "the Company") ANGLE WELCOMES NEW RESEARCH FROM BARTS SUPPORTING POTENTIAL USE OF PARSORTIX TO DETECT AND MONITOR PROSTATE CANCER Simple blood test could become effective diagnostic ANGLE p...

All News

DateHeadlineSource
28-11-16ISSUE OF SHARE OPTIONSRNS
24-11-16Result of GMRNS
04-11-16ANGLE welcomes new research supporting Parsortix StockMarketWire
04-11-16Barts Research Supports Potential Use of ParsortixRNS
01-11-16Notice of GMRNS
27-10-16Director's share purchaseRNS
07-10-16Holding(s) in CompanyRNS
04-10-16Result of AGMRNS
30-09-16ANGLE notes research results in Clinical ChemistryStockMarketWire
30-09-16Research published in Clinical ChemistryRNS
19-09-16Issue of EquityRNS
09-09-16Annual Report and Accounts and Notice of AGMRNS
04-08-16MD Anderson Cancer Center poster presentationRNS
02-08-16Edison issues ADR update on AngleRNS
28-07-16ANGLE revenue upStockMarketWire
28-07-16Use of Parsortix in GANNET53 drug trialRNS
28-07-16Preliminary ResultsRNS
27-07-16ANGLE initiates ovarian cancer study in the USStockMarketWire
27-07-16Initiation of 200 patient US ovarian cancer studyRNS
19-07-16ANGLE initiates European ovarian cancer study StockMarketWire
19-07-16Initiation of European ovarian cancer studyRNS
15-07-16Notice of ResultsRNS
15-07-16Parsortix gaining traction at EACR ConferenceRNS
01-06-16Holding(s) in CompanyRNS
31-05-16Holding(s) in CompanyRNS
27-05-16Edison research update on AngleStockMarketWire
27-05-16Edison issues research update on AngleRNS
25-05-16ANGLE wins contract with Cancer Research UKStockMarketWire
25-05-16Cancer Research UK ContractRNS
25-05-16PlacingRNS
29-04-16NEW PUBLICATIONS UTILISING PARSORTIXRNS
22-04-16AIM share tips 2016: the first four monthsInteractive Investor
19-04-16Edison research update on AngleStockMarketWire
19-04-16Edison issues research update on AngleRNS
18-04-16ANGLE's Parsortix potential in metastatic breast cancerStockMarketWire
18-04-16Parsortix potential in metastatic breast cancerRNS
21-03-16Are Today’s Double-Digit Rises Just The Start For Filtronic Plc, Angle plc And ReNeuron Group Plc?Motley Fool
21-03-16Edison issues research update on AngleRNS
21-03-16Parsortix potential for prostate cancer detectionRNS
09-03-16ANGLE granted European patent for ParsortixStockMarketWire

RSS feeds

  • Editorial news feed for LSE:AGL Editorial
  • Regulatory news feed for LSE:AGL Regulatory